Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504770 | 0.83 | CHRM1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL3226142 | 0.81 | CHRM1 (0.36) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL157028 | 0.80 | — | — | |
| SCHEMBL329299 | 0.80 | — | — | |
| SCHEMBL1157667 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL21219177 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL487333 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL21225948 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL3182058 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL11554076 | 0.78 | TDP1 (0.38) | FFAR3ALDH1A1TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476486-B1 | PROCESS FOR PREPARING A HIGH-MOLECULAR POLYAMIDE, POLYESTER, COPOLYESTER, COPOLYAMIDE OR POLYESTER-AMIDE BLOCK COPOLYMER | DSM IP ASSETS BV (NL) | 2007-07-11 | — | — | EP | claimed |
| EP-0960894-B1 | Group IVB metal blowing catalyst compositions for the production of polyurethane foams | AIR PROD & CHEM (US) | 2005-08-03 | — | — | EP | claimed |
| EP-0125617-B1 | Method for producing a metallized polymer from the polymer composition | NISSAN CHEMICAL IND LTD (JP) | 1993-12-08 | — | — | EP | claimed |
| CN-111479806-B | D-amino acid oxidase inhibitors and therapeutic uses thereof | 心悦生医股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-108368235-B | On-demand curable moisture-curable urethane-containing fuel-resistant prepolymers and compositions thereof | PRC-迪索托国际公司 | 2021-06-25 | — | — | CN | disclosed |
| EP-2511273-B1 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | HIVIH (FR) | 2019-05-15 | — | — | EP | disclosed |
| EP-2697213-B1 | INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES | HIVIH (FR) | 2018-12-12 | — | — | EP | disclosed |
| EP-2945932-B1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN INC (US) | 2018-11-21 | — | — | EP | disclosed |
| US-9982015-B2 | Cyclin based inhibitors of CDK2 and CDK4 | UNIVERSITY OF SOUTH CAROLINA (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170218018-A1 | CYCLIN BASED INHIBITORS OF CDK2 AND CDK4 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-03 | — | — | US | disclosed |
| US-9604900-B2 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | LABORATOIRE BIODIM (FR) | 2017-03-28 | — | — | US | disclosed |
| EP-1399448-A1 | IMIDAZO 1,5-A] PYRIMIDO 5,4-D] BENZAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-03-24 | — | — | EP | disclosed |
| US-6686352-B2 | USEFUL AS COGNITIVE ENHANCER OR FOR THERAPY OF COGNITIVE DISORDERS LIKE ALZHEIMER'S DISEASE | HOFFMANN-LA ROCHE INC. | 2004-02-03 | — | — | US | disclosed |
| US-20030148487-A1 | 1,3-dicarbonyl-dioxygenase - a new c-c-bond cleaving enzyme | CODEXIS, INC. | 2003-08-07 | — | — | US | disclosed |
| US-6548512-B1 | Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-04-15 | — | — | US | disclosed |
| US-20030055042-A1 | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives | F. HOFFMANN-LA ROCHE AG A SWISS COMPANY (CH) | 2003-03-20 | — | — | US | disclosed |
| WO-2003016428-A2 | TRIBOLUMINESCENT MATERIALS AND DEVICES CONTAINING THEM | QINETIQ LIMITED (GB) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003016427-A2 | PHOTOLUMINESCENT COMPOUNDS | QINETIQ LIMITED (GB) | 2003-02-27 | — | — | WO | disclosed |
| WO-2002094834-A1 | IMIDAZO [1,5-A] PYRIMIDO [5,4-D] BENZAZEPINE DERIVATIVES AS GABA A RECEPTOR MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-11-28 | — | — | WO | disclosed |
| US-6020357-A | CARDIOVASCULAR DISORDERS; ANTCOAGULANTS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170218018-A1 | CYCLIN BASED INHIBITORS OF CDK2 AND CDK4 | CDK4, CDK2, CDK8 | FFAR3 4342/4885ALDH1A1 4528/4885TDP1 2445/4885 |
| US-20030055042-A1 | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives | GALR1, GALR2, ADRA1A | FFAR3 138/4885ALDH1A1 444/4885TDP1 3985/4885 |
| US-20030148487-A1 | 1,3-dicarbonyl-dioxygenase - a new c-c-bond cleaving enzyme | ALDH7A1, CMBL, DDO | FFAR3 3943/4885ALDH1A1 86/4885TDP1 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.